|
Canada-0-DIAMONDS कंपनी निर्देशिकाएँ
|
कंपनी समाचार :
- KYMRIAH® (tisagenlecleucel) | Official Patient Website
KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that is either relapsing (went into remission, then came back) or is refractory (did not go into remission after receiving other leukemia treatments)
- KYMRIAH® (tisagenlecleucel) | B-cell ALL Treatment
Learn about KYMRIAH for the treatment of pediatric and young adult r r acute lymphoblastic leukemia See full Prescribing Safety Info, including Boxed Warning KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that has
- What to Expect With KYMRIAH® (tisagenlecleucel)
KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients with large B-cell lymphoma, a type of non-Hodgkin lymphoma, that has relapsed (went into remission, then came back) or is
- What to Expect With KYMRIAH
Treatment with KYMRIAH uses your own cells, so the process begins with T cell collection A small, temporary tube (intravenous or IV catheter) will be placed into your vein to collect your T cells KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients with follicular lymphoma (FL), a type of
- KYMRIAH® (tisagenlecleucel) | DLBCL Treatment
KYMRIAH ® (tisagenlecleucel) is a treatment for patients with relapsed or refractory (r r) diffuse large B-cell lymphoma (DLBCL) Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in
- Understanding KYMRIAH
KYMRIAH is a prescription cancer treatment used in patients with follicular lymphoma (FL), a type of non-Hodgkin lymphoma, that has relapsed (went into remission, then came back) or is refractory (did not go into remission after receiving other lymphoma treatments) after having at least two other kinds of treatment There are ongoing studies to confirm the benefit of KYMRIAH in FL
- KYMRIAH® (tisagenlecleucel) Treatment Center Locator
KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that is either relapsing (went into remission, then came back) or is refractory (did not go into remission after receiving other leukemia treatments)
- Diffuse Large B-cell Lymphoma (DLBCL) Treatment - KYMRIAH
What is KYMRIAH? Learning that your cancer has returned or isn’t responding to treatment is devastating However, there may be another option that is different from what you’ve been treated with in the past KYMRIAH is a therapy specifically made for patients like you, with relapsed refractory (r r) DLBCL
- Pediatric ALL Treatment | KYMRIAH® (tisagenlecleucel)
Is KYMRIAH right for me? KYMRIAH ® (tisagenlecleucel) is approved to treat children and young adults whose B-cell acute lymphoblastic leukemia (ALL) is refractory or in second or later relapse KYMRIAH is a therapy option for those looking for a different way to try to treat their cancer because previous treatments have not kept their cancer in remission
- What to Expect With KYMRIAH® (tisagenlecleucel)
Others get a referral for KYMRIAH from their primary oncologist If you haven’t already selected your treatment center, view the list of participating KYMRIAH Treatment Centers, or call KYMRIAH CARES™ at 1-844-4KYMRIAH (1-844-459-6742) for an up-to-date list of treatment centers in the United States so you can find a center near you
|
|